Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma?
- 31 December 2003
- Vol. 134 (6) , 918-922
- https://doi.org/10.1016/s0039-6060(03)00416-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas: a review of 282 casesBritish Journal of Surgery, 2003
- Evolving Surgical Management for Patients with PheochromocytomaJournal of Clinical Endocrinology & Metabolism, 2001
- Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomasJournal of Internal Medicine, 2001
- [123I]Metaiodobenzylguanidine and [111In]Octreotide Uptake in Benign and Malignant PheochromocytomasJournal of Clinical Endocrinology & Metabolism, 2001
- Comparison of Somatostatin Analog and Meta-Iodobenzylguanidine Radionuclides in the Diagnosis and Localization of Advanced Neuroendocrine TumorsJournal of Clinical Endocrinology & Metabolism, 2001
- Radiopharmaceuticals for Nuclear Endocrinology at the University of MichiganCancer Biotherapy & Radiopharmaceuticals, 2000
- Early surgical history of phaeochromocytomaBritish Journal of Surgery, 1987
- Pheochromocytoma in Sweden 1958–1981Acta Medica Scandinavica, 1986
- Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumorsSeminars in Nuclear Medicine, 1985
- PheochromocytomaCirculation, 1956